Company intelligence / Profile preview

Bella Forme Group

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Bella Forme Group operates in the wellness, fitness, beauty, and medical aesthetics sectors. Its medical division offers minimally invasive awake liposuction procedures using local anesthesia for body contouring with short downtimes. The company also provides a range of medically supervised weight loss programs utilizing FDA-approved medications such as semaglutide and tirzepatide. Clinical results for these interventions are consistent with published data on their efficacy in weight management.

Therapeutic areas: OtherEndocrinology
Modalities: DeviceSmall moleculeInjection therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Bella Forme Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bella Forme Group.

Explore the full profile